Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07516769 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Nicorandil as Anti-inflammatory in Rheumatoid Arthritis

Study acronym: RA
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Interventions: Nicorandil 10 MG Oral Tablet (Drug) to Nicorandil 5 MG Oral Tablet (Drug)v4
  2. Re-verified, no change to tracked fieldsv3
  3. Primary endpoint(s) modified Recruitment opened · Start date changed from estimate of Apr 2026 to Nov 1, 2024 · Secondary endpoints revised (3) · 1 morev2 Show 4 more changesShow less
    • Recruitment opened
    • Start date changed from estimate of Apr 2026 to Nov 1, 2024
    • Secondary endpoints revised (3)
    • Site details revised

    See this version in full on ClinicalTrials.gov ↗

  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to evaluate the possible efficacy and safety of nicorandil as anti-inflammatory in managing patients with active rheumatoid arthritis.
Trial Details
NCT Number NCT07516769
Lead Sponsor Tanta University
Conditions Rhumatoid Arthisis
Enrollment 46 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov